1. Introduction
===============

Mycotoxins are fungal secondary metabolites which, if ingested, can evoke a wide range of toxic responses and disease conditions in higher vertebrates. Cyclopiazonic acid (α-cyclopiazonic acid; CPA, [Figure 1](#toxins-01-00074-f001){ref-type="fig"}) is an indole-tetramic acid mycotoxin produced by the ubiquitous genera of molds *Aspergillus* and *Penicillium*. Beside colonizing various grains and seeds \[[@B1-toxins-01-00074],[@B2-toxins-01-00074]\], these molds can grow on many food substrates, such as cheese and meat products \[[@B3-toxins-01-00074],[@B4-toxins-01-00074],[@B5-toxins-01-00074]\]. Therefore, CPA can contaminate a number of agricultural commodities, animal feeds, and food sources. This toxin has been found in edible tissue in poultry, milk, and eggs \[[@B6-toxins-01-00074],[@B7-toxins-01-00074],[@B8-toxins-01-00074]\] presumptively due to animals' consumption of contaminated feeds. Despite the wide presence of CPA, few incidents of animal mycotoxicosis and no confirmed incident of human poisoning have been attributed to CPA. Despite its early discovery, the benign nature of CPA has rendered it to receive much less attention of the mycotoxin research community than its counterparts such as aflatoxins, trichothecenes, fumonisins and ochratoxins in the past two decades.

![Structure of α-CPA.](toxins-01-00074-g001){#toxins-01-00074-f001}

The chemistry and biochemistry of the synthesis of CPA, which was carried out primarily in a *Penicillium* strain, received considerable attention in the 1970s. Some intermediates and enzymes involved in their formation and/or conversions were purified (for a review, see \[[@B9-toxins-01-00074]\] and references therein). The chemical characterization of CPA also has elicited a tremendous interest in studies of biologically active natural products containing the tetramic acid structural motif, an important class of nitrogen-containing heterocycles \[[@B10-toxins-01-00074],[@B11-toxins-01-00074],[@B12-toxins-01-00074]\]. The detailed revelation of CPA formation, especially the aspects of molecular biology and enzymatic mechanisms, however, had been lacking until the recent identification of three clustered biosynthetic genes in *Aspergillus flavus* and closely related *Aspergillus oryzae* \[[@B13-toxins-01-00074],[@B14-toxins-01-00074],[@B15-toxins-01-00074]\]. This review aims to provide an historic overview of CPA studies and the most recent progress made in the elucidation of CPA biosynthesis.

2. CPA-Producing Fungi
======================

Cyclopiazonic acid is named after the strain, *Penicillium cyclopium* Westling \[[@B16-toxins-01-00074]\], from which it was originally isolated. However, *P. cyclopium* or its synonym *P. aurantiogriseum* \[[@B17-toxins-01-00074]\] have not been found to make CPA, and the CPA-producing strain originally isolated (CSIR 1082) was later identified as *P. griseofulvum* Dierckx \[[@B18-toxins-01-00074]\]. Other species of *Penicillium* including *P. griseofulvum*, *P. camemberti*, *P. urticae* and *P. commune* have been reported to consistently produce CPA \[[@B19-toxins-01-00074]\]. Other species of *P. chrysogenum*, *P. nalgiovense,P. crustosum*, *P. hirsutum* and *P. viridicatum* also have been reported to produce CPA \[[@B20-toxins-01-00074]\] but CPA production by these taxa has not been confirmed. Certain *Aspergillus* species such as *A. flavus*, *A. oryzae*, *A. fumigatus, A. versicolor,* and *A. tamarii* also produce CPA \[[@B21-toxins-01-00074],[@B22-toxins-01-00074],[@B23-toxins-01-00074]\]. In a recent survey, Vinokurova *et al.* \[[@B24-toxins-01-00074]\] found that 30% of the *A. fumigatus* and *A. phoenicis* strains but only one of 21 *A. versicolor* strains were able to produce CPA. The low incidence of CPA production by *A. versicolor* warrants a further examination since *A. versicolor* Tiraboschi originally reported to produce CPA \[[@B25-toxins-01-00074]\] was later identified as *A. oryzae* \[[@B26-toxins-01-00074]\].

toxins-01-00074-t001_Table 1

###### 

Percentage of CPA-producing *A. flavus* isolates from various regions of the world.

  Sources                                              No.^a^   BG^b^   AF/CPA   AF/−   −/CPA   −/−   References
  ---------------------------------------------------- -------- ------- -------- ------ ------- ----- ----------------------------
  Peanuts, soybean, wheat, Argentina                   87       5       27       2      57      14    \[[@B27-toxins-01-00074]\]
  Peanuts, Argentina                                   38       2       79       0      21      0     \[[@B28-toxins-01-00074]\]
  Peanuts, Argentina                                   29       3       49       3      24      24    \[[@B29-toxins-01-00074]\]
  Soils, Argentina                                     218L     8       77       11     11      1     \[[@B30-toxins-01-00074]\]
                                                       73S              88       4      8       0     
                                                       70N              78       9      10      3     
  Dried vine berries, Argentina                        5                0        0      100     0     \[[@B31-toxins-01-00074]\]
  Grain, smoked dried meat products, Croatia           96               0        10     5       85    \[[@B32-toxins-01-00074]\]
  Corn, wheat, feeds, Hungary                          32               0        0      59      41    \[[@B33-toxins-01-00074]\]
  Sour lime, India                                     25               20       40     ?       ?     \[[@B34-toxins-01-00074]\]
  Soils, Iran                                          58               21       7      22      50    \[[@B35-toxins-01-00074]\]
  Peanuts, Israel                                      200              19       73     4       4     \[[@B36-toxins-01-00074]\]
  Maize, Italy                                         62       8       45       21     13      21    \[[@B37-toxins-01-00074]\]
  Almonds, Portugal                                    15       1       20       0      0       80    \[[@B38-toxins-01-00074]\]
  Feeds, Queensland                                    31       7       65       3      22      10    \[[@B39-toxins-01-00074]\]
  Cocoa beans, Spain                                   100      20      15       32     17      36    \[[@B40-toxins-01-00074]\]
  Maize, US                                            19               58       5      16      21    \[[@B41-toxins-01-00074]\]
  Soils, US                                            774L             71       \<1    12      16    \[[@B42-toxins-01-00074]\]
                                                       309S             99       \<1    \<1     0     
  Corn, nuts, animals and humans, Brazil, Uganda, US   54               26       7      26      41    \[[@B43-toxins-01-00074]\]

a: Number of total strains used in the calculation. L indicates strains that produce large sclerotia; S, small sclerotia and N, no sclerotia.

b: Number of strains that produce B- and G-type aflatoxins not included in the calculation.

CPA and aflatoxins often co-contaminate crops \[[@B41-toxins-01-00074],[@B42-toxins-01-00074],[@B44-toxins-01-00074],[@B45-toxins-01-00074],[@B46-toxins-01-00074],[@B47-toxins-01-00074],[@B48-toxins-01-00074]\]. The source of these mycotoxins is complicated by the fact that both *aspergilli* and *penicillia* are often found in the same crop and as well as after grain storage \[[@B49-toxins-01-00074],[@B50-toxins-01-00074],[@B51-toxins-01-00074],[@B52-toxins-01-00074],[@B53-toxins-01-00074]\]. The most important aflatoxin producers are members in the *Aspergillus* section *Flavi*, particularly *A. flavus*, *A. parasiticus*, and *A. nomius*. Some strains of other members such as *A. pseudotamarii* \[[@B54-toxins-01-00074]\], *A. tamarii*, *A. toxicarius*, and *A. bombycis* \[[@B55-toxins-01-00074]\] also have been reported to produce aflatoxins. *A. flavus* has been divided into two subtypes based on sclerotial size \[[@B56-toxins-01-00074],[@B57-toxins-01-00074],[@B58-toxins-01-00074]\]. The type with small sclerotia (S~B~ or A. *flavus* Group IB) is found together with the L-morphotype (large sclerotia \> 400 um) as crop and soil contaminants on all continents except Antarctica. Small sclerotia-producing isolates from crops in Thailand that resemble *A. flavus* S~B~ strains but produce both B- and G- aflatoxins have been called *A. flavus var. parvisclerotigenus* \[[@B59-toxins-01-00074]\]. This taxonomic identification has never been recognized as authoritative, and in an independent investigation of *Aspergillus* section *Flavi* isolates from Thailand certain isolates with small sclerotia and the ability to produce both B- and G- aflatoxins have been identified as a variant clade of *A. nomius* rather than *A. flavus* \[[@B60-toxins-01-00074]\]. Atypical *A. flavus* isolates (also called strain S~BG~ or *A. flavus* Group II), which produce small sclerotia and are intermediate between *A. flavus* and *A. parasiticus* have been identified in soil and agricultural samples from West Africa, Argentina and Australia \[[@B28-toxins-01-00074],[@B58-toxins-01-00074],[@B61-toxins-01-00074]\]. These S~BG~ isolates have recently been classified as *A. minisclerotigenes* and *A. arachidicola* \[[@B62-toxins-01-00074]\]. Only *A. minisclerotigenes* produces CPA. Isolates of these new taxa are also possibly found in the United States (Texas) \[[@B58-toxins-01-00074],[@B61-toxins-01-00074]\] and Europe (Italy, Portugal, and Spain) \[[@B37-toxins-01-00074],[@B38-toxins-01-00074],[@B40-toxins-01-00074]\]. Since the original finding of CPA production by *A. flavus* \[[@B63-toxins-01-00074]\], the relationship between CPA and aflatoxin production by *A. flavus* and the closely related *A*. *parasiticus* has been investigated. Typical *A. flavus* isolates can produce only B-type aflatoxins and CPA, and *A. parasiticus* always produces B- and G-type aflatoxins but never CPA \[[@B23-toxins-01-00074]\]. [Table 1](#toxins-01-00074-t001){ref-type="table"} summarizes the ability of *A. flavus* isolates to produce CPA and aflatoxins from various regions of the world. The atypical B- and G-type producers are excluded in [Table 1](#toxins-01-00074-t001){ref-type="table"}. As can be seen, the ability of *A. flavus* isolates to produce CPA varies greatly. The incidence of CPA production by *A. flavus* is high (\>70%) in Argentina and in the United States ([Table 1](#toxins-01-00074-t001){ref-type="table"}).

3. Toxicological and Pathological Effects of CPA
================================================

The toxicity of CPA is attributed to its ability to alter normal intracellular calcium flux through the specific inhibition of sarcoplasmic or endoplasmic reticulum calcium-dependent ATPase (SERCA) essential for calcium uptake as in the muscle contraction-relaxation cycle, which results in increased muscle contraction \[[@B64-toxins-01-00074],[@B65-toxins-01-00074]\]. SERCA also plays a crucial role in other body cells. It serves a housekeeping function, maintaining high calcium in the endoplasmic reticulum and low cytosolic calcium. This calcium gradient is vital for the cell and controls proliferation, differentiation and cell death. Most recent evidence shows that CPA inhibits the calcium pump by blocking the calcium access channel and immobilizing a subset of four transmembrane helices of the ATPase \[[@B66-toxins-01-00074]\]. Besides the specific inhibition of ATPase activity, CPA induced various pathological lesions in test animals \[[@B19-toxins-01-00074]\].

In rats, intraperitoneal injection of CPA has been reported to cause lesions of the liver, kidney, pancreas, spleen, and heart \[[@B67-toxins-01-00074]\]. The oral LD~50~ value for CPA in nonpregnant mice was 64 mg/kg body weight, and the toxicity syndromes included ptosis, hypokinesia, hypothermia, tremor, cessation of food and water intake and resulting cachexia. The intensity of these toxic syndromes was dose-dependent. In pregnant mice, a single oral pulse dose of CPA (15 to 50 mg/kg) decreased body weight gain and the pregnancy rates significantly \[[@B68-toxins-01-00074]\].In feeding studies broiler chickens fed 100 ppm of CPA had a high mortality rate and decreased weight gain. Postmortem examination showed that the chickens had proventricular lesions characterized by mucosal erosion and hyperemia, yellow foci in livers and spleens. Microscopic examination of tissues showed ulcerative proventriculitis, mucosal necrosis in the gizzard, and hepatic and splenic necrosis and inflammation. Chickens fed 50 ppm CPA had thick mucosa and dilated proventricular lumens as well as hyperplasia of the proventricular mucosal epithelium. CPA at 10 ppm, however, did not cause significant lesions \[[@B22-toxins-01-00074]\]. Dogs administered CPA at 0.5 mg/kg or 1.0 mg/kg died before the end of 90-day study period, which suggests a much lower no-observable-effect level (NOEL) than other small animals. Gross lesions of diffuse hyperemia with focal areas of hemorrhage and ulceration and microscopic lesions of necrosis, vasculitis, lymphoid necrosis, and karyomegaly in organs were apparent \[[@B69-toxins-01-00074]\]. Surprisingly, among the large mammals, pigs appear to be quite sensitive to CPA with a NOEL of approximately 1.0 mg/kg \[[@B70-toxins-01-00074]\].

The effects of CPA (50 mg/kg) and aflatoxin (3.5 mg/kg) on broiler chickens, in most cases, were additive \[[@B71-toxins-01-00074]\]. Chickens treated with CPA and aflatoxin had increased weights of the liver, kidney, and pancreas, showed signs of proventriculitis, had decreased concentrations of serum albumin and phosphorus, and increased concentrations of blood urea nitrogen and serum glutamic oxalacetic transaminase. Postmortem examination showed that the chickens fed CPA and aflatoxin exhibited similar pathological effects as those fed CPA alone, which included thickened mucosa and dilated proventricular lumens, hard fibrotic spleen, and atrophy of the gizzard.

The IC~50~ of CPA on cell proliferation was 40-fold lower than ochratoxin (OTA) in an *in vitro* test using purified lymphocytes from piglets \[[@B72-toxins-01-00074]\]. The combined effect of CPA and OTA based on IC~20~ on the proliferation of porcine lymphocytes was additive \[[@B73-toxins-01-00074]\]. The individual and combined effect of CPA (34 mg/kg) and OTA (2.5 mg/kg) to broiler chickens were examined \[[@B74-toxins-01-00074]\]. CPA reduced body weight to about 80% of the control, but it did not affect the relative weight of liver, kidney, pancreas except for proventriculus. The interaction of CPA and OTA was additive. The pathological lesions were similar to those caused by CPA and aflatoxin. Animals had increased weights of liver, kidney, pancreas, and proventriculus, decreased serum total protein and albumin, and increased triglycerides, uric acid and creatine kinase activity; creatine is important in maintaining the ATP level for skeletal muscle contraction. Postmortem examination revealed similar pathological lesions as those caused by CPA and aflatoxin.

The feeding of CPA (34 mg/kg) and T-2 toxin (6 mg/kg) also caused reduced performance and adversely affected the health of broiler chickens \[[@B75-toxins-01-00074]\]. A synergistic interaction between CPA and T-2 for relative liver and kidney weights, serum cholesterol and triglyceride concentrations was observed. This combination also affected the 3-week body weight significantly. CPA and T-2 can induce cell death in lymphoid organs \[[@B76-toxins-01-00074]\]. The immunopathological effect of 10 ppm CPA and 1 ppm T-2 in combination included decreases in both thymic CD~8~^+^ lymphocyte and splenic CD~4~^+^ and CD~8~^+^ lymphocytes \[[@B77-toxins-01-00074]\].

CPA is not a potent acute toxin because its oral LD~50~ in rats is in the range of 30 to 70 mg/kg \[[@B68-toxins-01-00074],[@B78-toxins-01-00074]\]. Few incidents of animal mycotoxicosis have been reported because of the benign nature of CPA, the small amounts usually present, or the fact its effects may be masked by other concurrent mycotoxins. Both CPA and aflatoxins were isolated from peanut meal related to the turkey 'X' disease that caused the death of 100,000 turkeys in England in the early 1960s \[[@B79-toxins-01-00074],[@B80-toxins-01-00074]\]. Although aflatoxins were regarded as the main culprit, CPA likely contributed to some of the observed pathological clinical signs, such as catarrhal or haemorrhagic enteritis and opisthotonus that are not characteristic of aflatoxicosis \[[@B79-toxins-01-00074],[@B81-toxins-01-00074]\].

Despite the CPA-induced pathological effects in test animals, field incidents of CPA mycotoxicoses in humans have not been reported. Nonetheless, it has been speculated that CPA may be associated with 'kodo poisoning,' a toxic reaction characterized by nausea, vomiting, depression, intoxication and unconsciousness after consumption of CPA-contaminated Kodo millet in some parts of North India \[[@B78-toxins-01-00074],[@B82-toxins-01-00074]\]. Based on a NOEL of 1 mg/kg/day and taking into consideration species variability, for humans approximately 10 μg/kg/day or 700 μg/day was suggested as the maximum acceptable daily intake (ADI) dose \[[@B19-toxins-01-00074]\].

4. Biosynthesis of CPA
======================

Chemically, CPA belongs to the family of indole-tetramic acid secondary metabolites. *P. griseofulvum* Dierckx (originally called *P. cyclopium*) showed the maximal rate of CPA production after cessation of growth in Czapek's medium. Research to elucidate the mechanism of CPA biosynthesis was carried out primarily in this strain in the 1970s. The origin of the carbon skeleton of CPA was established by feeding studies using radiolabeled substrates \[[@B83-toxins-01-00074]\]. Chemical degradation analysis indicated that CPA is derived from tryptophan, a C5-unit formed from mevalonic acid and two molecules of acetic acid. The incorporation efficiencies of sodium \[1-^14^C\]acetate, \[2-^14^C\] mevalonic acid, and indole-labeled tryptophan were 3.5%, 7.0%, and 24.7%, respectively. The efficient incorporation of labeled tryptophan strongly suggested that it is a direct precursor of CPA. Further studies showed that all carbon atoms of the tryptophan were incorporated into CPA \[[@B84-toxins-01-00074]\]. The presence of both β-CPA (bis-secodehydrocyclopiazonic acid) and CPA in mycelia suggested that β-CPA may be a precursor \[[@B85-toxins-01-00074]\]. As further evidence for β-CPA being the precursor, the time-course of metabolite production showed that, when only trace amounts of CPA were produced, β-CPA predominated, while as CPA formation increased, the amount of β-CPA declined. After feeding \[1-^14^C\]acetate-labeled β-CPA 67% was converted to CPA, while 18% remained as β-CPA \[[@B83-toxins-01-00074]\]. The compound *γ,γ*-dimethylallyltryptophan was known to be a precursor of ergot alkaloids \[[@B86-toxins-01-00074],[@B87-toxins-01-00074],[@B88-toxins-01-00074]\]. Incubation of a cell-free-extract (CFE) with a mixture of radiolabeled \[^3^H\]tryptophan and \[1-^14^C\] dimethylallyl diphosphate (DMAPP) did not yield CPA labeled with either ^3^H or ^14^C although the resulting β-CPA contained 19% of the added ^14^C, but no ^3^H \[[@B89-toxins-01-00074]\]. This result showed that the labeled DMAPP, but not tryptophan could be incorporated into β-CPA by the CFE. This study showed that CPA formation was different from ergot alkaloid biosynthesis, in the latter biosynthesis involves direct prenylation of tryptophan by DMAPP \[[@B86-toxins-01-00074],[@B90-toxins-01-00074]\]. Subsequent studies found that the substrate for DMAPP in the CFE was α-acetyl-γ-(β-indolyl)methyltetramic acid (cycloacetoacetyl-L-tryptophan, cAATrp) \[[@B84-toxins-01-00074]\]. The CFE converted exogenously supplied cAATrp and DMAPP into β-CPA in 1:1 stoichiometry. The responsible enzyme in the CFE was designated as cycloacetoacetyltyptophanyl dimethylallyl transferase. This enzyme, also called β-CPA synthase or dimethylallyl cycloacetoacetyl typtophan synthase (DCAT-S) was purified by McGrath *et al.* (1977). It has a molecular weight of 95 kDa with an isoelectric point of 5.3. Its concentration reached a maximum at 60 hr during fermentation. This synthase is very specific for DMAPP and cAATrp and could not use isopentenyl diphosphate (IPP, an isomer of DMAPP), tryptophan or *N*-acetyltryptophan as substrates \[[@B91-toxins-01-00074]\]. The dimethylallyl tryptophan synthases of *Clavices purpurea*, *Aspergillus fumigatus, Aspergillus nidulans* and *Malbranchea aurantiaca* for alkaloid biosynthesis are α~2~ dimers \[[@B86-toxins-01-00074],[@B92-toxins-01-00074]\] suggesting that the β-CPA synthase is also likely to be a dimer. The enzyme(s) for the formation of cAATrp was never isolated from *P. griseofulvum* Dierckx. Schabort *et al.* \[[@B93-toxins-01-00074]\] isolated five isozymes, designated as β-cyclopiazonate oxidocyclase that catalyzed oxidation and cyclization of β-CPA to CPA; each of the β-cyclopiazonate oxidocylases has a covalently linked flavin. Spectrophotometric titration studies of oxidized β-cyclopiazonate oxidocyclase with substrate analogs showed that the NH group in the tetramic acid residue is involved in binding to the active site \[[@B94-toxins-01-00074],[@B95-toxins-01-00074]\].

4.1. The mevalonate pathway key to CPA formation in A. flavus
-------------------------------------------------------------

Mevalonate is the primary precursor of DMAPP, which is also a major component in the production of terpenoids. The biosynthetic steps leading to the formation of mevalonic acid have been well characterized \[[@B96-toxins-01-00074]\] and are shown in [Scheme 1](#toxins-01-00074-f004){ref-type="scheme"}. They include condensation of acetyl-CoA and acetoacetyl-CoA by 3-hydroxy-3-methylglutaryl (HMG)-CoA synthase and a subsequent reduction by HMG-CoA reductase.In eukaryotes, conversion of mevalonic acid to DMAPP involves two consecutive phosphorylations at position C5 by mevalonate kinase and phosphomevalonate kinase, respectively \[[@B97-toxins-01-00074]\]. The subsequent decarboxylation carried out by diphosphomevalonate decarboxylase (or mevalonate-5-diphosphate decarboxylase), followed by dehydration produces isopentenyl diphosphate (IPP). IPP is a common intermediate for a number of pathways including those for the synthesis of terpenoids, steroids and carotenoids, and prenyl moieties of sirodesmin and ergot alkaloids. IPP is then isomerized by IPP isomerase to DMAPP, a potent electrophile \[[@B98-toxins-01-00074]\]. DMAPP can alkylate other molecules, including IPP, to generate a variety of isoprenoid compounds found in nature such as plant hormones, mycotoxins, antimicrobial agents, and pharmaceutically important antibiotics.

![Biosynthesis of dimethylallyldiphosphate (DMAPP).](toxins-01-00074-g004){#toxins-01-00074-f004}

The availability of full genome sequences for many organisms makes it possible to locate physically linked genes in a genome and to quickly obtain gene copy number. The genome sequences of *A. oryzae* RIB40 (ATCC 42149) and *A. flavus* NRRL3357 are available for such analysis at http://www.bio.nite.go.jp/dogan/Top and http://www.aspergillusflavus.org/genomics/, respectively. Both genomes are about 37 Mb and organized in eight chromosomes \[[@B99-toxins-01-00074],[@B100-toxins-01-00074]\]. These genome databases provide a remarkable wealth of information about identity, function, and physical location of many genes. Candidate genes involved in the anabolism and catabolism of mevalonic acid thus can be readily identified from respective genome databases ([Table 2](#toxins-01-00074-t002){ref-type="table"}). The genes encoding key enzymes in DMAPP biosynthesis are not clustered and appear as multiple copies. There are two copies of genes encoding 3-hydroxy-3-methylglutaryl (HMG)-CoA synthase and HMG-CoA reductase and one copy each of genes encoding mevalonate kinase, phosphomevalonate kinase, and diphosphomevalonate decarboxylase. The predicted enzymes contain a conserved Gly/Ser-rich region probably involved in the binding of ATP known as a GHMP (abbreviations from their substrates, galacto-, homoserine, mevalonate and phosphomevalonate) kinase N terminal domain as well as a GHMP kinase C terminal domain. The mevalonate kinase gene and the diphosphomevalonate decarboxylase gene are about 190 kb apart on chromosome 3, and the phosphomevalonate kinase gene is 50 kb from one of the two HMG-CoA synthase genes on chromosome 8. The two IPP isomerase genes are located on chromosome 3 and about 300 kb apart.

toxins-01-00074-t002_Table 2

###### 

Predicted loci associated with the metabolism of mevalonic acid.

  Enzyme                                      Gene Locus^a^    Location
  ------------------------------------------- ---------------- -----------------------------------------
  \`3-Hydroxy-3-methylglutaryl-CoA synthase   AFL2G_02388.2    Contig 2, 2508858\~2510466 −
                                              AFL2G_11649.2    Contig 14, 1056212\~1057748 −
                                              AO090003000611   Chromosome 2, SC003,1640889\~1642497 +
                                              AO090010000487   Chromosome 8, SC010, 1307684\~1309220 −
  HMG-CoA reductase                           AFL2G_08234.2    Contig 9, 779011\~783044 -
                                              AFL2G_12082.2    Contig 15, 462348\~465804 -
                                              AO090120000217   Chromosome 5, SC113, 541346\~544055 -
                                              AO090103000311   Chromosome 8, SC103, 805908\~807609 +
  Mevalonate kinase                           AFL2G_04604.2    Contig 4, 2076279\~2077883 −
                                              AO090023000793   Chromosome 3, SC023, 2058446\~2060050 -
  Phosphomevalonate kinase                    AFL2G_11633.2    Contig 14, 1009373\~1011005 -
                                              AO090010000471   Chromosome 8, SC010, 1260354\~1261854 -
  Pyrophosphomevalonate decarboxylase         AFL2G_04673.2    Contig 4: 2266676\~2268145 -
                                              AO090023000862   Chromosome 3, SC023, 2250974\~2252258 −
  Isopentenyl pyrophosphate isomerase         AFL2G_04341.2    Contig 4, 1322573\~1323720 +
                                              AFL2G_04245.2    Contig 4: 1026352\~1027394 +
                                              AO090023000500   Chromosome 3, SC023, 1306204\~1307211 +
                                              AO090023000391   Chromosome 3, SC023, 1004129\~1005046 +

a: AFL2G indicates *A. flavus* genes and AO indicates *A. oryzae* genes.

4.2. The gene cluster involved in CPA biosynthesis is adjacent to the aflatoxin gene cluster in A. flavus/oryzae
----------------------------------------------------------------------------------------------------------------

The aflatoxin gene cluster of *A. flavus* NRRL3357resides in a subtelomeric region on chromosome 3. Even before the genome sequences of *A. oryzae* and *A. flavus* became available it was suspected that the genes involved in CPA production are located close to the aflatoxin gene cluster because many *A. flavus* strains unable to produce aflatoxins also did not produce CPA. Further analysis found that such isolates lost large portions of or the entire aflatoxin gene cluster up to the telomere \[[@B101-toxins-01-00074]\]. *A. oryzae* is closely related to *A. flavus,* and some strains also produce CPA \[[@B15-toxins-01-00074]\]. In the effort to generate *A. oryzae* mutants that do not produce aflatoxins, CPA, kojic acid, and 3-nitropropionic acid for producing polypeptides, Christensen *et al.* \[[@B102-toxins-01-00074]\] gamma-irradiated *A. oryzae* BZ14, an isolate derived from *A. oryzae* IFO 04177, which contains the aflatoxin gene cluster. They obtained two CPA-negative mutants, BECh1 and BECh 2, which lost the aflatoxin pathway *aflR* and *omtA* genes. Because *aflR* and *omtA* are 22 kb apart in the genomes of *A. flavus* and *A. parasiticus*, gamma radiation treatment must have caused deletion of a large portion of DNA containing genes encoding proteins involved in aflatoxin biosynthesis and CPA biosynthesis. From this study it was suspected that part of the deleted region is associated with CPA production. Christensen *et al.* \[[@B103-toxins-01-00074]\] later isolated the dimethylallyl-cycloacetoacetyl-L-tryptophan synthase (DCAT-S) gene from an *A. oryzae* A1560 (=IFO 04177) isolate. Disruption of this gene resulted in the loss of CPA production.

![Schematic representation of the PKS-NRPS involved in synthesis of cAATrp. The different domains are shown in the arrow (KS, ketosynthase; AT, acyl transferase; DH, dehydratase; MeT, methyltransferase; ER, enoyl reductase; KR, ketoreductase; ACP, acyl carrier protein attachment site; C, condensation domain; A, adenylation domain; T, thiolation domain; R, releasing domain). Brackets indicate the domains are defective. The numbers below the arrow indicate approximation amino acid distance from the *N*-terminus for the domains.](toxins-01-00074-g002){#toxins-01-00074-f002}

In *A. oryzae* RIB40, which is unable to produce CPA, the aflatoxin gene cluster boundary gene *norB* is about 19 kb from the telomere at one end on chromosome 3 ([Figure 3](#toxins-01-00074-f003){ref-type="fig"}) suggesting that the DCAT-S gene is located between the aflatoxin gene cluster and the telomere. In the genome of *A. oryzae* NBRC 4177 (=IFO 04177), a CPA-producing strain, an additional region is present extending beyond the telomere in the RIB40 strain ([Figure 3](#toxins-01-00074-f003){ref-type="fig"}). Tokuoka *et al.* \[[@B15-toxins-01-00074]\], using PCR profiling with oligoprimers derived from the same region in the *A. flavus* NRRL3357 genome sequence combined with an inverse PCR technique, identified the telomeric repeat and determined that the size of the region in *A. oryzae* NBRC 4177 extending beyond the telomere of *A. oryzae* RIB40 is about 17 kb. Sequencing of the region around the RIB40 telomere in *A. oryzae* NBRC 4177 revealed a gene predicted to encode a hybrid polyketide synthase (PKS)-nonribosomal peptide synthase (NRPS). This *pks-nrps* gene is 11.7 kb and lacks introns. In addition, other genes in this region include: *cpaB* (encoding the DCAT-S), *cpaC,* predicted to encode a cytochrome P450 monooxygenase, a gene possibly encoding a methyltransferase, and *cpaT,* predicted to encode a transporter. As with other secondary metabolite gene clusters, clustering of genes may allow efficient coordinated regulation of gene expression when CPA production is necessary.

Extensive PCR profiling of the 100-kb subtelomeric region of *A. flavus* strains of various chemotypes and closely related *A. parasiticus* strains, which produce aflatoxins, but not CPA, suggested that a CPA biosynthesis cluster is next to the aflatoxin gene cluster \[[@B13-toxins-01-00074]\]. Four genes were characterized in this putative CPA gene cluster by gene disruption: *maoA*, predicted to encode a monoamine synthase, *dmaT*,the gene encoding the dimethylallyltryptophan synthase, *pks-nrps*, and a Zn~2~Cys~6~ transcription factor-encoding gene, *ctfR1* ([Figure 3](#toxins-01-00074-f003){ref-type="fig"}). Consistent with studies performed on *A. oryzae*, disruption of *dmaT* (=the DCAT-S gene) and *pks-nrps* abolished CPA production \[[@B15-toxins-01-00074],[@B102-toxins-01-00074]\]. Knockout studies confirmed that the gene *maoA* is also required for CPA biosynthesis. Surprisingly, disruption of *ctfR1*, which was expected to be required for transcriptional regulation of the CPA cluster genes, did not affect CPA production. A 3-kb region between the aflatoxin gene cluster and *maoA* in *A. flavus* did not contain ORFs likely to encode proteins related to CPA biosynthesis (see [Figure 3](#toxins-01-00074-f003){ref-type="fig"}). Therefore, *maoA*, *dmaT*, *pks-nrps* constitute the CPA gene cluster in *A. flavus*. A search of the putative promoter region for the *pks-nrps* for potential Zn~2~Cys~6~ protein binding sites revealed a sequence, 5'-TCGTGGACGA-3', which is quite similar to AflR-binding sites \[[@B104-toxins-01-00074]\]. If AflR is acting as the pathway specific regulatory protein for both the aflatoxin and the CPA gene clusters, this would explain their apparent co-regulation under similar media conditions and the reason why proximity to the aflatoxin gene cluster is maintained.

5. Characterization of the Enzymes Involved in CPA Biosynthesis
===============================================================

5.1. Formation of cAATrp by CpaS, a hybrid PKS-NRPS
---------------------------------------------------

Formation of the first stable intermediate in CPA biosynthesis, *cyclo*-acetoacetyl-L-tryptophan (cAATrp), in *A. flavus/oryzae* requires catalysis by the 431 kDa multifunctional CPA synthase (CpaS or CpaA), a PKS/NRPS polypeptide with seven functional and four non-functional catalytic domains \[[@B14-toxins-01-00074],[@B15-toxins-01-00074]\] ([Figure 2](#toxins-01-00074-f002){ref-type="fig"}) The PKS portion of CpaS contains three functional domains, a ketosynthase (KS), an acyl transferase (AT), and an acyl carrier protein (ACP) domains that catalyze formation of acetoacetyl-CoA by condensation of one molecule of acetyl-CoA with one molecule of malonyl-CoA. Domains of dehydratase (DH), methyltransferase (MT), enoylreductase (ER) and ketoreductase are present in the CpaS but lack critical amino acids necessary for catalytic activity \[[@B14-toxins-01-00074]\]. After condensation of two molecules of acetate by the KS, the acetoacetyl moiety is tethered on ACP. The NRPS portion of CpaS shown in [Figure 2](#toxins-01-00074-f002){ref-type="fig"} has catalytic domains common to many NRPSs, including a condensation domain (C, amino acids 2501-2793), an adenylation domain (A, amino acids 2980-3392) to activate an amino acid for loading, a thiolation domain (T, amino acids 3481-3546) that is an attachment site of the growing peptide on the phosphopantetheinylated peptidyl carrier protein (PCP), and a releasing domain (R, amino acids 3593-3619) to release the product peptide from the enzyme. The biosynthesis steps leading to cAATrp are shown in [Scheme 2](#toxins-01-00074-f005){ref-type="scheme"}.

![Conversion of acetylCoA to cAATrp by the hybrid PKS-NRPS. A. Formation of the cAATrp precursor catalyzed by the KS, AT, ACP, A, and C domains. B. Dieckmann cyclization to form cAATrp catalyzed by the R domain.](toxins-01-00074-g005){#toxins-01-00074-f005}

Amino acid selection by the A domain is dependent on signature amino acids in the domain that have not been well defined \[[@B105-toxins-01-00074]\]. However a tool is available that predicts whether or not large (aromatic amino acids) or small amino acids will be accepted by the A domain \[[@B106-toxins-01-00074]\]. Prediction for CpaS is that large amino acids such as Trp or Phe will be recognized by its A-domain. How Trp rather than Phe is recognized by the CpaS A-domain has not been determined. During synthesis of cAATrp, the adenylation domain activates the substrate Trp which is then transferred to the pantetheine cofactor of the neighboring peptidyl carrier protein (PCP) domain (the T domain in [Figure 2](#toxins-01-00074-f002){ref-type="fig"}) \[[@B107-toxins-01-00074]\].

Gulick \[[@B105-toxins-01-00074]\], in reviewing the required conformation dynamics for catalysis by NRPSs, found evidence for a domain alternation strategy between the A and T domains that consists of two catalytic steps: the first involving the initial adenylation of the amino acid carboxylate moiety to form an acyl-AMP intermediate and the second involving formation of the thioester. He suggested that the enzymes use a 140° domain rotation to present opposing faces of the two domains to the active site in order to allow both partial reactions. The crystal structure of a four-domain NRPS SrfA-C protein, which is similar to CpaS, was determined and demonstrated that the A domain is rotated away from the *N*-terminal T domain, thereby allowing the PCP domain to interact with the neighboring C domain. The PCP domain is not positioned so that it could donate the pantetheine arm to either the A domain or the R domain.

The C domains of NRPSs are known to catalyze amide bond formation between two PCP-tethered amino acids \[[@B108-toxins-01-00074],[@B109-toxins-01-00074]\]. For CpaS, condensation occurs between the ACP-tethered acetoacetyl moiety and the PCP-tethered tryptophan and forms an amide bond. Condensation requires the involvement of the highly conserved HHXXXDX~14~Y motif found in all modular C domains \[[@B110-toxins-01-00074]\]. The Asp and second His were found to be essential for catalytic activity. Following condensation the substrate remains tethered to the PCP phosphopantetheinyl arm in the T domain.

Comparisons of both hybrid PKS-NRPS and NRPS enzymes show that the most downstream domain of the NRPS module acts as the chain-terminating module. Therefore, the release of the condensation product acetoacetyl-Trp is likely to be mediated by such an R domain. The role of the R domain in the release of the metabolite from the PKS-NRPS has recently been found to occur without the expected NADH/NADPH reduction even though the R domain contains an NADH/NADPH binding domain (GXXG/SXXG) near its *N*-terminus \[[@B111-toxins-01-00074]\]. However, the domain lacks a functional short chain dehydrogenase/reductase (SDR) catalytic triad (Ser-Tyr-Lys) characteristic of similar NRPSs and other enzymes (aldehyde reductase, epimerases) known to use such domains for thioester and ester hydrolysis. In CpaS, the Tyr is replaced by Leu in this triad which would prevent catalytic function as a reductase. Other amino acids further toward the *C*-terminus of the R-domain were found to be necessary for catalysis, in particular, Asp3803 and His3843. The His residue could be involved in proton abstraction necessary to form the resonance-stabilized acetoacyl carbanion shown in [Scheme 2](#toxins-01-00074-f005){ref-type="scheme"}A. It is this carbanion that attacks the thioester carbonyl by Dieckmann condensation to cyclize acetoacetyl-Trp and release it from PCP to form the indole tetramate, cAATrp.

5.2. Conversion of cAATrp to β-CPA
----------------------------------

Conversion of cAATrp to β-CPA ([Scheme 3](#toxins-01-00074-f006){ref-type="scheme"}) involves alkylation of the C-4 position of the Trp indole ring by DMAPP, a reaction catalyzed by cycloacetoacetyltyptophanyl dimethylallyl transferase \[[@B91-toxins-01-00074]\] encoded by the CPA-cluster gene, *dmaT*. The transferase also is called dimethylallyl cycloacetoacetyl typtophan synthase (DCAT-S) or designated as CpaD \[[@B111-toxins-01-00074]\]. *A. flavus* and *A. oryzae* DMATs consist of 437 amino acids with a calculated molecular weight of 49 kDa, and the functional form likely is a dimer as reported for many dimethylallyl tryptophan synthases involved in the synthesis of alkaloids. There are at least nine *dmaT* homologs in the *A. flavus* genome, but only the *dmaT* in the CPA gene cluster is associated with a *pks-nrps* gene.

Involvement of dimethylallyl tryptophan synthases (DMATs) in other biosynthetic processes has been well documented. Some of these DMATs may be used in synthesis of alkaloids related to ergot, where the first committed step in the biosynthesis is tryptophan prenylation. Since disruption of the CPA-cluster *dmaT* prevents CPA biosynthesis, the DMAT in the CPA cluster appears to be the only DMAT able to catalyze prenylation of cAATrp. The presence of *dmaT* in the CPA gene cluster supports the assembly-line nature of β-CPA biosynthesis similar to those characterized for NRPSs in prokaryotes. Catalytic activity has recently been studied by analyzing the crystal structure of a complex of *A. fumigatus* DMAT with L-tryptophan \[[@B112-toxins-01-00074]\].

![Conversion of cAATrp to α‑CPA.](toxins-01-00074-g006){#toxins-01-00074-f006}

The protein forms a β/α barrel fold called a prenyltransferase barrel. Enzymes with similar structure are found in bacteria but have no sequence similarity to fungal DMATs. The crystal structure revealed that dimethylallyl diphosphate is positioned selectively in the enzyme over position 4 of the Trp indole nucleus ([Scheme 3](#toxins-01-00074-f006){ref-type="scheme"}). The reaction catalyzed by DMAT is an electrophilic alkylation, (Friedel-Crafts alkylation), of an aromatic ring. The energy barrier for cation formation that precedes the alkylation is overcome by tight interactions with Arg and Lys residues in the catalytic pocket that offset the diphosphate negative charges. The resulting carbocation is stabilized by five Tyr residues to provide a hydrophobic pocket that prevents reaction of the carbocation with water. Just as in a typical Friedel-Crafts reaction Mg^2+^ facilitates the alkylation.

5.3. Conversion of β-CPA to α-CPA is catalyzed by the monoamine oxidase MaoA (CpaO)
-----------------------------------------------------------------------------------

The final step in the biosynthesis of α-CPA is the dehydrogenation of β-CPA resulting in intramolecular ring closure ([Scheme 3](#toxins-01-00074-f006){ref-type="scheme"}, bottom). The enzyme involved in this conversion (CpaO) is a FAD-dependent oxidoreductase that has some of the properties of typical monoamine oxidases. Early studies suggested that the CPA oxidoreductase first generates an unstable eneimine which then undergoes intramolecular cyclization \[[@B94-toxins-01-00074],[@B95-toxins-01-00074],[@B113-toxins-01-00074],[@B114-toxins-01-00074]\]. The role of the flavin prosthetic group in catalysis by FAD-dependent oxidases has been the subject of much study and although the ring-closure appears surprisingly simple the mechanism for the catalysis is still under scrutiny \[[@B115-toxins-01-00074],[@B116-toxins-01-00074],[@B117-toxins-01-00074]\]. The deprotonated (rather than the protonated) amine moiety on the substrate initially binds to the active site on the monoaminoxidase and is oxidized to the protonated imine with the covalently bound FAD cofactor being reduced to its hydroquinone form. To complete the catalytic cycle, the reduced FAD cofactor reacts with O~2~ to generate oxidized flavin and H~2~O~2~. Characterized monoamine oxidases exist as membrane-bound dimeric proteins. In human monoamine oxidase A (MaoA), substrate binding and oxidation occur in elongated cavities extending from the flavin site at the core of the enzyme to the surface of the protein on the opposite side of the FAD adenosine ring. From crystal structure determinations, the cavity of the enzyme is hydrophobic. C-H bond cleavage is catalyzed by monoamine oxidases to form the protonated imine; the cleavage could involve transfer of a proton, a hydride or a hydrogen atom to the flavin.

Unlike the usual oxidations catalyzed by monamine oxidases which involve proton transfer to the flavin \[[@B116-toxins-01-00074]\], the oxidation of β-CPA by CpaO could be initiated by a hydride shift mechanism similar to that postulated for cyclizations catalyzed by the berberine bridging enzyme oxidases \[[@B116-toxins-01-00074],[@B118-toxins-01-00074],[@B119-toxins-01-00074],[@B120-toxins-01-00074]\]. The steps most likely involve hydride transfer to the N4-flavin nitrogen to generate a stabilized cation that undergoes the ring closure as shown in [Scheme 4](#toxins-01-00074-f007){ref-type="scheme"}. A radical intermediate could just as easily explain the ring closure steps. However, Edmondson *et al.* \[[@B116-toxins-01-00074]\] suggested that a polar mechanism for monoamine oxidase catalysis fits theoretical calculations best. Formation of an unstable eneimine intermediate as previously suggested \[[@B95-toxins-01-00074]\] is unlikely and ring formation probably occurs immediately upon hydride transfer without accumulation of an intermediate.

![Possible mechanism for oxidative ring-closure of β-CPA to α-CPA by the flavin-dependent monoamine oxidase, MaoA (CpaO).](toxins-01-00074-g007){#toxins-01-00074-f007}

6. Genetic Diversity in CPA Biosynthesis of *A. flavus* and *A. oryzae*
=======================================================================

The gene preceding *maoA* of the CPA gene cluster in *A. oryzae* RIB40 and NBRC 4177 encodes a P450 monooxygenase while in the same relative location in *A. flavus* NRRL3357 and AF13 no such a gene is present ([Figure 3](#toxins-01-00074-f003){ref-type="fig"}). The unique location of this *p450* gene (=*cpaC*) in *A. oryzae* is reminiscent of the same gene organization in the *Aspergillus* S~BG~ isolate BN008R (ATCC MYA379) collected from Benin, West Africa \[[@B61-toxins-01-00074],[@B121-toxins-01-00074]\]. A comparison of the 12 kb region beyond the *norB* gene in BN008R to the corresponding region in RIB40 shows that they share \> 95% nucleotide identity (\>98% in the *maoA* and the *p450* coding regions). *A. oryzae* mutants with *p450* deleted failed to produce mono- and dihydroxy CPA when compared to the wild type \[[@B122-toxins-01-00074]\]. Since the *p450* gene is missing in CPA-producing *A. flavus* NRRL3357 and AF13 ([Figure 3](#toxins-01-00074-f003){ref-type="fig"}), it is not directly involved in CPA biosynthesis. It is not known whether *A. oryzae* RIB40 gained the *p450* gene or *A. flavus* NRRL3357 lost the *p450* gene.

![Partial and complete CPA clusters in different strains of *A. flavus* and *A. oryzae*. The AF biosynthesis cluster is shown above the scale (kb).](toxins-01-00074-g003){#toxins-01-00074-f003}

RIB40 and NRRL3357 exhibit other unique differences; the former has the type I deletion in its *norB-cypA* region, an S-strain signature, while the latter has the type II deletion that is often associated with aflatoxigenic L-strain *A. flavus* isolates \[[@B123-toxins-01-00074]\]. They also have distinct single nucleotide polymorphisms in the *omtA* and *dmaT* genes involved in aflatoxin and CPA biosynthesis, respectively \[[@B58-toxins-01-00074],[@B123-toxins-01-00074]\] (and unpublished results). *A. flavus* populations are genetically diverse. *A. oryzae* is believed to be selected or to have evolved from certain groups of nonaflatoxigenic *A. flavus*. *A. oryzae* strains are classified into three groups based on deletion patterns in the aflatoxin gene cluster \[[@B124-toxins-01-00074],[@B125-toxins-01-00074]\]. Group 1 has all aflatoxin gene orthologs, group 2 has the region beyond the *ver1* gene deleted but contains a DNA segment of unknown origin, and group 3 has the partial aflatoxin gene cluster up to the *vbs* gene (see [Figure 3](#toxins-01-00074-f003){ref-type="fig"}). Group 3 resembles the E, F, and G deletion patterns in nonaflatoxigenic and CPA-negative *A. flavus* isolates \[[@B101-toxins-01-00074]\], which lack the genome region beyond the respective partial aflatoxin gene cluster (connected to telomeric repeat). Since the CPA gene cluster in *A. oryzae* resides next to the aflatoxin gene cluster as in *A. flavus*, group 3 likely has lost the CPA gene cluster. Group 2 strain RIB62 has been confirmed to be lacking the CPA gene cluster resulting from a large deletion \[[@B125-toxins-01-00074]\]. Some strains of group 1 *A. oryzae* still maintain the ability to produce CPA, such as NBRC 4177 while other strains have lost the ability, such as RIB40 due to a truncation that caused the loss of more than half of the *pks-nrps* gene.

A PCR survey of the strains of *A. oryzae* and *A. flavus* and related *A. parasiticus* and *A. sojae* ([Table 3](#toxins-01-00074-t003){ref-type="table"}) showed that only isolates of nonaflatoxigenic and CPA-positive L-strain *A. flavus*, with the type I, S-strain genetic signature in a previously characterized clade, for example, MS1-1, NC3-6, SC3-5 and TX21-9 \[[@B123-toxins-01-00074]\] also have the *p450* gene.

toxins-01-00074-t003_Table 3

###### 

Sclerotial, genetic, and toxin-producing characteristics of isolates of *Aspergillus* species.

  *Species*        *Strain*    *Sclerotial Morphotype^a^*   *AF/CPA Production^b^*   *norB-cypA Pattern^c^*   *p450^d^*
  ---------------- ----------- ---------------------------- ------------------------ ------------------------ -----------
  A. flavus        CA28        S                            +/+                      I                        N
                   CA42        S                            +/+                      I                        N
                   CA43        S                            +/+                      I                        N
                   CA44        S                            +/+                      I                        N
                   AF12        S                            +/+                      I                        N
                   AF70        S                            +/+                      I                        N
                   GA10-18     S                            +/+                      I                        N
                   VA4-36      S                            +/+                      I                        N
                   AF13        L                            +/+                      II                       N
                   CA14        L                            +/+                      II                       N
                   CA19        L                            +/+                      II                       N
                   GA9-9       L                            +/+                      II                       N
                   GA13-9      L                            +/+                      II                       N
                   NRRL3357    L                            +/+                      II                       N
                   VA2-9       L                            +/+                      II                       N
                   LA4-5       L                            −/+                      I                        N
                   SC6-9       L                            −/+                      I                        N
                   TX9-8       L                            −/+                      I                        N
                   GA4-4       L                            −/+                      II                       N
                   LA10-4      L                            −/+                      II                       N
                   MS1-1       L                            −/+                      I                        Y
                   NC3-6       L                            −/+                      I                        Y
                   SC3-5       L                            −/+                      I                        Y
                   TX21-9      L                            −/+                      I                        Y
  A. oryzae        NBRC 4177   ?                            −/+                      ?                        Y
                   RIB40       N                            −/−                      I                        Y
                   SRRC304     N                            −/?                      I                        Y
                   SRRC493     N                            −/?                      I                        Y
                   SRRC2044    N                            −/?                      I                        Y
  A. parasiticus   BN009       L                            +/−                      intact                   N
                   SRRC2043    L                            +\*/−                    intact                   N
                   SRRC2999    L                            +/−                      intact                   N
  A. sojae         SRRC299     N                            −/?                      intact                   N
                   SRRC1123    N                            −/?                      intact                   N
                   SRRC1126    N                            −/?                      intact                   N

a: S and L indicate S-strain and L-strain isolates based on the size of sclerotia produced.

b: I and II indicate type I and type II deletions in the *norB-cypA* region.

c: The *p450*-specific oligonucleotides used in PCR, tgtgacggtggatggcgagc and tcaatggctttgtactccag, were derived from identical regions of *A. oryzae* RIB40 and *Aspergillus* S~BG~ strain, BN008R.

As mentioned earlier, atypical *A. flavus* S~BG~ isolates have been classified into the new taxa of *A. minisclerotigenes* and *A. arachidicola* \[[@B62-toxins-01-00074]\]. *A. minisclerotigenes* differs from *A. arachidicola*. in that it produces CPA like *A. parvisclerotigenus*, previously named *A. flavus var. parvisclerotigenus* by Saito and Tsuruta \[[@B59-toxins-01-00074]\], which included largely S~B~ strains and only a small number of S~BG~ strains \[[@B56-toxins-01-00074],[@B59-toxins-01-00074]\]. Genetic evidence shows that the *β*-tubulin gene sequence of the *A. parvisclerotigenus* strain, CBS 121.62^T^, isolated from Nigeria by Hesseltine *et al.* \[[@B56-toxins-01-00074]\], is different from those of the *A. minisclerotigenes* strains and this strain produced other metabolites, such as A30461 and speradine A not produced by *A. minisclerotigenes* \[[@B62-toxins-01-00074]\].

Although Saito and Tsuruta \[[@B59-toxins-01-00074]\], in their naming of *A. flavus var. parvisclerotigenus*, included morphologically similar S~BG~ isolates obtained by Hesseltine *et al.* \[[@B56-toxins-01-00074]\], Ehrlich *et al.* \[[@B60-toxins-01-00074]\] considered the S~BG~ isolates collected from different regions of Thailand by Saito and Tsuruta \[[@B59-toxins-01-00074]\] a variant clade of *A. nomius* rather than *A. flavus*. The S~BG~*Aspergillus* BN008R isolated from Benin, West Africa \[[@B61-toxins-01-00074]\] likely is *A. minisclerotigenes*. We hypothesize that the common ancestor of the aforementioned nonaflatoxigenic and CPA-positive L-strain *A. flavus* isolates and the group 1 *A. oryzae* that contain the *p450* gene may be *A. minisclerotigenes* or *A. flavus var. parvisclerotigenus.* The loss of both B- and G-type aflatoxins renders them to be regarded as *A. flavus* due to the morphological and cultural similarities to other clades of *A. flavus*. Probably, two genetic variants are responsible for CPA production in *A. flavus*. One is the S~B~*A. flavus* strains that always have the type I *norB-cypA* deletion, and another is L-strain *A. flavus* strains with the type II deletion, which are either aflatoxigenic or nonaflatoxigenic.

7. Possible Advantage of CPA to Fungi
=====================================

Like aflatoxins, the benefit of CPA to the producing fungi is not clear. CPA is an excellent chelator of iron. CPA production is greatest during the period preceding dormancy when growth has practically stopped. Because concentrations of free iron in soil are usually low, it would be beneficial to fungi to have a readily available supply of iron for subsequent growth. Riley and Goeger \[[@B126-toxins-01-00074]\] speculated that stockpiles of CPA-chelated iron would be conducive to rapid fungal growth for occupying a niche in the saprophytic environments. Similar to a siderophore, which is an iron-chelating compound secreted by bacteria, fungi, and plants, CPA probably fulfilled partly this ion-chelating function long ago before a true siderophore took its place. Many siderophores are nonribosomal peptides and dissolve ions by chelation as soluble Fe^3+^ complexes that are taken up by active transport mechanisms. In the *A. flavus* genome, in the same subtelomeric region where the CPA gene cluster resides, *sidC* and *sidT* (*msf2*) genes encoding a siderophore and a siderochrome-iron transporter, respectively, have been identified \[[@B13-toxins-01-00074]\]. Their location, which is at a terminus of chromosome 3, suggests that they were acquired later than the CPA gene cluster to carry out the iron-chelating function.

8. Conclusions
==============

The CPA and aflatoxin gene clusters are contiguous on the subtelomeric region of chromosome 3 in the *A. flavus* and *A. oryzae* genomes. The enzyme functions of the three CPA genes correlate well with current as well as previous studies of the biosynthesis of this indole-tetramic acid product. Although CPA is not a potent acute toxin and few incidents of mycotoxicoses have been reported, aflatoxin B~1~ is a potent carcinogen. Little is known about the synergistic effects of the two toxins and more research is needed especially because plans are being considered to apply nonaflatoxigenic *A. flavus* strains in large amounts to control aflatoxin contamination in corn, cottonseed, and peanuts and some *A. oryzae* strains used in food fermentation are capable of CPA production. With knowledge of the co-localization of the two gene clusters it is now easy to explain why strains of *A. flavus* and *A. oryzae* have different abilities to produce aflatoxin and CPA. This understanding has significant health implications. The genetic diversity of *A. flavus* and *A. oryzae* in the region adjoining the CPA gene cluster suggests a divergence of *A. flavus* from *A. oryzae*. We suggest that *A. oryzae* most likely descended from an ancestor that was the precursor of the *Aspergillus* S~BG~ variant, while *A.flavus* descended from a precursor of *A. parasiticus*.
